Releasing the Brakes on Cancer Immunotherapy
- PMID: 26348216
- DOI: 10.1056/NEJMp1510079
Releasing the Brakes on Cancer Immunotherapy
Similar articles
-
Cancer treatment: The killer within.Nature. 2014 Apr 3;508(7494):24-6. doi: 10.1038/508024a. Nature. 2014. PMID: 24695297 No abstract available.
-
New checkpoint inhibitors ride the immunotherapy tsunami.Nat Rev Drug Discov. 2013 Jul;12(7):489-92. doi: 10.1038/nrd4066. Nat Rev Drug Discov. 2013. PMID: 23812256 No abstract available.
-
Recruiting T cells in cancer immunotherapy.Science. 2021 Apr 9;372(6538):130-131. doi: 10.1126/science.abd1329. Science. 2021. PMID: 33833111 No abstract available.
-
[Progress in cancer immunotherapy].MMW Fortschr Med. 2017 Aug;159(14):48-53. doi: 10.1007/s15006-017-9949-y. MMW Fortschr Med. 2017. PMID: 28924719 Review. German. No abstract available.
-
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials.Immunity. 2020 Jan 14;52(1):36-54. doi: 10.1016/j.immuni.2019.12.010. Immunity. 2020. PMID: 31940272 Review.
Cited by
-
Development of a human glioblastoma model using humanized DRAG mice for immunotherapy.Antib Ther. 2023 Oct 4;6(4):253-264. doi: 10.1093/abt/tbad021. eCollection 2023 Oct. Antib Ther. 2023. PMID: 38075240 Free PMC article.
-
Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy.Bioengineering (Basel). 2024 Jan 18;11(1):93. doi: 10.3390/bioengineering11010093. Bioengineering (Basel). 2024. PMID: 38247970 Free PMC article. Review.
-
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.Cell Mol Immunol. 2020 Aug;17(8):807-821. doi: 10.1038/s41423-020-0488-6. Epub 2020 Jul 1. Cell Mol Immunol. 2020. PMID: 32612154 Free PMC article. Review.
-
Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer.Molecules. 2022 Jun 13;27(12):3798. doi: 10.3390/molecules27123798. Molecules. 2022. PMID: 35744922 Free PMC article. Review.
-
Clinical trials of CAR-T cells in China.J Hematol Oncol. 2017 Oct 23;10(1):166. doi: 10.1186/s13045-017-0535-7. J Hematol Oncol. 2017. PMID: 29058636 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources